BCL10 is rarely mutated in human prostate carcinoma, small cell lung cancer, head and neck tumours, renal carcinoma and sarcomas

British Journal of Cancer

Volumn 80, Issue 10, 1999, Pages 1565-1568

  Gill, S ^a   Broni, J ^a   Jefferies, S ^a   Osin, P ^a   Kovacs, G ^b   Maitland, N J ^c   Eeles, R ^a   Edwards, S M ^a   Dyer, M J S ^a   Willis, T G ^a   Cooper, C S ^a   Henk, J ^d   Gore, M ^d   Rhys Evans, P ^d   Archer, D ^d   Bishop, K ^d   Solomon, E ^e   Hodgson, S ^e   McGurk, M ^e   Hibbert, J ^e   O'Connell, M ^e   Saunders, M ^f   Partridge, M ^e   Chevretton, E ^e   Calman, F ^e   Shotton, K ^g   Brown, A ^j   Whittaker, S ^h   Kirby, R ⁱ   Corbishley, C ⁱ   Dunsmuir, W ⁱ   more..

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF YORK   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f MOUNT VERNON HOSPITAL   (United Kingdom)

^g Kent Oncology Centre   (United Kingdom)

^h ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

ⁱ ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^j NONE

more..

Author keywords

BCL 10; Head and neck squamous cell cancers; Lung cancer; Mutation; Prostate cancer; Renal carcinoma; Sarcomas

Indexed keywords

ARTICLE; CANCER GENETICS; GENE MUTATION; HEAD AND NECK TUMOR; HUMAN; KIDNEY CARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; SARCOMA; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

EID: 0032989067     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690561     Document Type: Article

References (22)

1. Anglard P, Trahan E, Liu S, Latif F, Merino MJ, Lerman MI, Zbar B and Linchan WM (1992) Molecular and cellular characterisation of human renal cell carcinoma cell lines. Cancer Res 52; 348-356
2. Clark J, Lu YJ, Sidhar SK, Parker C, Gill S, Smedley D, Hamoudi R, Linchan WM, Shipley J and Cooper CS (1997) Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15: 2233-2239
3. Condie A, Ecles R, Borreson AL, Coles C, Cooper C and Prosser J (1993) Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis and hydroxylamine and osmium tetroxide techniques. Hum Mutat 2: 58-66
4. D'Amico AV, Whittington R, Malkowicz B, Schultz D, Blank K, Broderick GA, Tomaszewski JF, Renshaw AA, Kaplan I, Beard CJ and Wein A (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy or interstitial radiation therapy for clinically localised prostate cancer. JAMA 280: 969-974
5. Garvin AJ, Stanley WS, Bennett DD, Sullivan JL and Sens DA (1986) The in vitro growth, heterotransplanation and differentiation of a human rhabdomyosarcoma cell line. Am J Pathol 125: 208-217
6. Hoffman K, Bucher P and Tschopp J (1997) The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci 22: 155-156
7. Kinzler KW and Vogelstein B (1997) Cancer susceptibility genes. Gatekeepers and caretakers. Nature 386: 761
8. Koseki T, Inohara N, Chen S, Carrio R, Merino J, Hottiger MO, Nabel GJ and Nunez G (1999) CIPER, a novel NF κB activating protein containing a caspase recruitment domain with homology to Herpesvirus-2 protein E10. J Biol Chem 274:9955-9961
9. Lane DP (1992) p53, guardian of the genome. Nature 358: 15-16
10. Macintosh CA, Stower M, Reid N and Maitland NJ (1998) Precise microdissection of human prostate cancer reveals genetic heterogeneity. Cancer Res 58: 23-28
11. Matolesy A, Casali P, Warnke RA and Knowles DM (1996) Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated BCL-2 gene. Blood 88: 3937-3944
12. Migliazza A, Martinotti S, Chen W, Fusco C, Ye BH, Knowles DM, Offit K, Chaganti RS and Dalla Fevera R (1995) Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphomas. Proc Natl Acad Sci USA 92: 12520-12524
13. Nojima T, Wang Y-S, Abe S, Matsuna T, Yanawaki S and Nagashina K (1990) Morphological and cytogenetic studies of a human synovial sarcoma xenotransplanted into nude mice. Acta Pathol Jap 40: 487-493
14. Sambrook J, Fritsch EF and Maniatis T (1989) Molecular cloning: a labortory manual. Cold Spring Harbor Laboratory Press
15. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ, Gwilliam R, Ross M, Linchan WM, Birdsall S, Shipley J and Cooper CS (1996) The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Molecular Genet 5: 1333-1338
16. Sonobe H, Manabe Y, Furihara M, Iwata J. Oka T, Ohtsuki Y, Mizobuchi H, Yamamoto K, Kumano O and Abe S (1992) Establishment and characterisation of a new human synovial sarcoma cell line HS-SY-H. Lab Invest 67; 498-505
17. Thome M, Martinon F, Hofmann K, Rubio V, Steiner V, Schneider P, Maltmann C and Tschopp J (1999) Equine herpesvirus-2 E10 gene product, but not its cellular homologue, activates NF-κB transcription factor and c-Jun N-terminal kinase. J Biol Chem 274: 9962-9968
18. Vogelstein B and Kinzler KW (1993) The multistep nature of cancer. Trends Genet 9: 138-141
19. Willis TG, Jadayel DM, Du M-Q, Peng H, Perry A, Abdul-Rauf M, Price H Karran L, Majekodunmi O, Wlodarska I, Pan L, Crook T, Hamoudi R, Isaacson P and Dyer MJS (1999) BCL10 is involved in t(1;14)(p22:q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell 96: 35-45
20. Yan M, Lee J, Schilbach S, Goddard A and Dixit V (1999) mE10, a novel caspase recruitment domain containing proapoptotic molecule. J Biol Chem 274 (15): 10287-10292
21. Yaoita S, Ohoi R, Hayashi Y, Kuwabara E and Watanabe T (1989) Establishment and characterisation of TN-2 cell line from a neuroblastoma of the left adrenal gland (in Japanese) Hum Cell 2: 199
22. Zhang Q, Siebert R, Yan M, Hinzmann B, Cui X, Xue L, Rakestraw KM, Naeve CW, Beckmann G, Weisenberger DD, Sanger WG, Nowotny H, Vesely M, Callet-Bauchu E, Salles G, Dixit VM, Rosenthal A, Schlegelberger B and Morris SW (1999) Inactivating mutations and overexpression of BCL10, a caspase recruitment domain (CARD)-containing gene in MALT lymphoma with t(1;14)(p22;q32). Nature Genet 22: 63-68